<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Bernaz, E.L.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Trestian, V.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Conţu, O.I.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
</creators>
<titles>
<title xml:lang='ro'>Utilizarea acidului alfa-lipoic (thiogamma 600) în tratamentul complex al piciorului diabetic</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2006</publicationYear>
<relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1810-1852</relatedIdentifier>
<dates>
<date dateType='Issued'>2006-10-02</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Journal article</resourceType>
<descriptions>
<description xml:lang='ro' descriptionType='Abstract'>S-a efectuat un studiu randomizat al eficacităţii tratamentului polineuropatiei diabetice în picior diabetic cu acid alfa-lipoic (Thiogamma 600®). În grupul de control (n=20) scorul NISll s-a micşorat cu 1,3 ± 0,3 iar ]n cel de studiu (n=20) cu 3,8 ± 0,7 (p<0,01), fapt ce dovedeşte eficienţa administrării Thiogamma 600® la pacienţii cu picior diabetic.</description>
<description xml:lang='en' descriptionType='Abstract'>A randomized study of diabetic polineuropathy treatment efficacy of alpha lipoic acid (Thiogamma 600®) In the diabetic foot was carried out. The NISll score decreased in the control group with 1,3 ± 0,3 and In the study group with 3,8 ± 0,7 (p<0,01 ), that demonstrates the efficiency of the Thiogamma 600® administration in the patients with diabetic foot.</description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>